Forced Oxidative Degradation of Anti-Hepatitis C Drugs Sofosbuvir and Daclatasvir: Characterization and Quantification
Open Access
- 30 April 2024
- journal article
- research article
- Published by Oriental Scientific Publishing Company in Oriental Journal of Chemistry
- Vol. 40 (2) , 312-320
Abstract
This study focuses on the analysis of hepatitis C drugs, specifically sofosbuvir (SOF) and daclatasvir (DCL), and their oxidative products. The drugs were isolated and characterized using FTIR, 1HNMR, and Mass Spectrometry techniques. Additionally, the drugs were oxidized using cerium (IV) in the presence of sulfuric acid at 100ºC. A spectrophotometric method was developed for the quantitative analysis of SOF and DCL in pure and pharmaceutical forms. The oxidation of the drugs was monitored by back determination of residual Ce(IV) using Fe(II) with ferroin as an indicator at 510 nm. The method demonstrated good sensitivity with RSD%<1.0, and the data were statistically analyzed using t- and F-tests.Keywords
This publication has 22 references indexed in Scilit:
- Green RP-HPLC method for simultaneous determination of sofosbuvir, ledipasvir, velpatasvir antivirals and beyond in their bulk material and co-formulated productsMicrochemical Journal, 2022
- Eco friendly stability indicating HPTLC method for simultaneous determination of sofosbuvir and ledipasvir in pharmaceutical tablets and HPTLC-MS characterization of their degradation productsMicrochemical Journal, 2022
- Applying different spectroscopic techniques for the selective determination of daclatasvir using merbromin as a probe: Applications on pharmaceutical analysisLuminescence, 2021
- Improved spectral resolution for the rapid simultaneous spectrophotometric determination of sofosbuvir and daclatasvir as anti hepatitis C virus drugs in pharmaceutical formulation and biological fluid using continuous wavelet and derivative transformSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2021
- Developing a multidisciplinary HCV direct-acting antivirals utilization management and assessment programJournal of the American Pharmacists Association, 2021
- Forced Oxidative Degradation Pathways of the Imidazole Moiety of DaclatasvirJournal of Pharmaceutical Sciences, 2019
- Simultaneous quantification of simeprevir sodium: A hepatitis C protease inhibitor in binary and ternary mixtures with sofosbuvir and/or ledipasvir utilizing direct and H-point standard addition strategiesSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2018
- Electrochemical design of a new nanosensor based on cobalt nanoparticles, chitosan and MWCNT for the determination of daclatasvir: a hepatitis C antiviral drugRSC Advances, 2017
- RP-HPLC Method for Simultaneous Determination of Sofosbuvir and Ledipasvir in Tablet Dosage Form and Its Application to In Vitro Dissolution StudiesChromatographia, 2016
- Spectrophotometric determination of H2-receptor antagonists via their oxidation with cerium(IV)Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2007